# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 91-100 of 2723 results.
Niraparib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer
Status: Recruiting
Last Changed: Aug 11, 2020
First Received: Aug 11, 2020
Disease(s): Ovarian Cancer
Intervention(s): Niraparib
Locations: Tongji Hospital, Wuhan, Hubei, China
Risk of Ovarian Cancer in Patients With a Pelvic Mass
Status: Completed
Last Changed: Nov 08, 2011
First Received: Apr 19, 2006
Disease(s): Ovarian Cancer
Intervention(s): Biomarker Assay (CA125 and HE4)
Locations: Fujirebio Diagnostics, Inc, Malvern, Pennsylvania, United States
Richard Moore, Providence, Rhode Island, United States
Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer
Status: Recruiting
Last Changed: Jul 16, 2020
First Received: Jul 16, 2020
Disease(s): Ovarian Cancer
Intervention(s): Serial Transvaginal Ultrasonography
Locations: Markey Cancer Center, Lexington, Kentucky, United States
Trial of Pimasertib With SAR245409 or Placebo in Ovarian Cancer
Status: Completed
Last Changed: Dec 12, 2018
First Received: Sep 06, 2013
Disease(s): Ovarian Cancer
Intervention(s): Pimasertib once daily, Pimasertib placebo, SAR245409 placebo, SAR245409, Pimasertib twice daily
Locations: Research site, Augusta, Georgia, United States
Research site, Chicago, Illinois, United States
Research site, Indianapolis, Indiana, United States
Research site, Silver Spring, Maryland, United States
Research site, Boston, Massachusetts, United States
... and 30 other locations.
Live After an Epithelial Ovarian Cancer: Multidisciplinary Assessment of Effects and Long-term Remission in Patients Needs.
Status: Completed
Last Changed: Feb 10, 2017
First Received: Dec 23, 2014
Disease(s): Epithelial Ovarian Cancer
Intervention(s): Gynecological consultation
Locations: CHU, Besançon, France
Institut Bergonie, Bordeaux, France
Polyclinique Bordeaux Nord, Bordeaux, France
CHU, Caen, France
Centre François Baclesse, Caen, France
... and 14 other locations.
ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK
Status: Recruiting
Last Changed: Jan 27, 2020
First Received: Sep 19, 2017
Disease(s): Ovarian Cancer
Intervention(s): VS-6063, Paclitaxel, Carboplatin
Locations: University of California San Diego, San Diego, California, United States
Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer
Status: Completed
Last Changed: Feb 25, 2015
First Received: Aug 31, 2004
Disease(s): Ovarian Cancer
Intervention(s): Docetaxel, Carboplatin
Locations: Florida Gynecologic Oncology, Fort Myers, Florida, United States
Jupiter Medical Center-Gynecology Oncology and Gynecology, Jupiter, Florida, United States
Florida Hospital/Gyn/Onc Department, Orlando, Florida, United States
Hematology-Onc. Assoc. of The Quad Cities, Bettendorf, Iowa, United States
University of Iowa, Iowa City, Iowa, United States
... and 15 other locations.
Sentinel Lymph Node in Early Ovarian Cancer
Status: Completed
Last Changed: Oct 18, 2019
First Received: Mar 02, 2018
Disease(s): Ovarian Cancer
Intervention(s): sentinel node technique
Locations: Hospital Universitario y Politécnico La Fe, Valencia, Spain
NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018)
Status: Completed
Last Changed: Jan 15, 2019
First Received: Jan 15, 2019
Disease(s): Ovarian Cancer
Intervention(s): NGR-hTNF, Pegylated liposomal doxorubicin, Doxorubicin
Locations: Ospedale San Raffaele, Milan, Italy
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Istituto Europeo di Oncologia, Milan, Italy
Istituto Nazionale Tumori IRCCS Fondazione "Giovanni Pascale", Naples, Italy
EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer
Status: Completed
Last Changed: Aug 04, 2020
First Received: Dec 04, 2013
Disease(s): Ovarian Cancer
Intervention(s): Paclitaxel + Carboplatin every 3 weeks, Carboplatin monotherapy every 3 weeks, Weekly Paclitaxel and Carboplatin
Locations: Notre-Dame Hospital of the CHUM, Montréal, Canada
Herlev Hospital, Herlev, Denmark
Kuopio University Hospital, Kuopio, Finland
Service d'Oncologie Médicale - Centre Hospitalier d'Alès, Alès, France
Service d'Oncologie Médicale - ICO Paul Papin, Angers, France
... and 59 other locations.